tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports
Want to see KLRS full AI Analyst Report?

Kalaris Therapeutics (KLRS) Stock News & Sentiment

375 Followers
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
Premium
Company Announcements
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
25d ago
8K
KLRS
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
Premium
Ratings
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
2M ago
KLRS
Kalaris Updates TH103 Strategy and Highlights Cash Runway
Premium
Company Announcements
Kalaris Updates TH103 Strategy and Highlights Cash Runway
2M ago
8K
KLRS
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
Premium
Weekend Updates
Vizsla, Coty, Kalaris, Annexon, Brown & Brown Trending
4M ago
BRO
ANNX
Early Clinical Strength and Durability of TH103 Underpin Buy Rating on Kalaris Therapeutics
Premium
Ratings
Early Clinical Strength and Durability of TH103 Underpin Buy Rating on Kalaris Therapeutics
4M ago
KLRS
Kalaris Therapeutics Announces Oversubscribed $50 Million Financing
Premium
Company Announcements
Kalaris Therapeutics Announces Oversubscribed $50 Million Financing
5M ago
8K
KLRS
Kalaris Therapeutics Announces Positive Phase 1a Trial Data
Premium
Company Announcements
Kalaris Therapeutics Announces Positive Phase 1a Trial Data
5M ago
8K
KLRS
More KLRS News >

KLRS News on the Web

Kalaris Therapeutics initiated with an Overweight at Morgan Stanley
TipRanks News
Neutral
Kalaris Therapeutics Announces CFO Resignation, Finance Leadership Shift
TipRanks News
Neutral
Top Kalaris Therapeutics Executive Quietly Unloads Company Shares
TipRanks News
Neutral
Kalaris Therapeutics: Early TH103 Data in nAMD Support Buy Rating and Favorable Risk/Reward Despite Manufacturing Hurdles
TipRanks News
Bullish
Kalaris Therapeutics reports FY25 EPS ($2.85), consensus ($3.70)
TipRanks News
Bullish
Kalaris Therapeutics sees cash runway into 4Q27
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Kalaris Updates TH103 Strategy and Highlights Cash Runway
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
KLRS
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KLRS’s Media Buzz Sentiment?
Currently, no data Available
What is KLRS’s weekly average amount of articles?
Currently, no data Available
What is KLRS’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week